MAMihir R. Atreya

Mihir R. Atreya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mihir R. Atreya has a total of 219 co-authors. Here are the top co-authors by number of shared publications:

  • Riad Lutfi

    Riley Hospital For Children, Indianapolis, USA

    18 shared publications
  • Bereketeab Haileselassie

    Lucile Packard Children’s Hospital Stanford, Stanford University School of Medicine, Palo Alto, CA

    17 shared publications
  • Michael T. Bigham

    Akron Children’s Hospital, Akron, USA

    17 shared publications
  • Natalie Z. Cvijanovich

    UCSF Benioff Children’s Hospital Oakland, Oakland, USA

    17 shared publications
  • Jeffrey Nowak

    Children’s Hospital and Clinics of Minnesota, Minneapolis, USA

    16 shared publications
  • Julie C. Fitzgerald

    Division of Critical Care, Department of Anesthesiology and Critical Care, The University of Pennsylvania Perelman School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA

    16 shared publications

Latest Publications

  • Development and Validation of Temperature Trajectory-Based Phenotypes in Pediatric Sepsis: A Multicenter Retrospective Cohort Study, 2012–2018

    by Stephanie R. Brown, L. Nelson Sanchez-Pinto, Jocelyn R. Grunwell, Xiao Hu, Craig M. Coopersmith, Mihir R. Atreya, Colin M. Rogerson, Alon Geva, Tellen D. Bennett, Grace Chong, et al.

    OBJECTIVES: Sepsis is a heterogeneous syndrome resulting from a complex interaction between the infectious agent and the host response. In adults with sepsis, longitudinal temperature measurements have been used to identify phenotypes with distinct clinical characteristics, immune profiles, and outcomes. Our objective was to develop and validate temperature trajectory-based phenotypes in critically ill children with sepsis. We hypothesized that the temperature trajectory-based phenotypes would be independently associated with clinical outcomes. DESIGN: Retrospective observational cohort study. SETTING: A total of 13 PICUs in the United States from January 1, 2012, to January 1, 2018. PATIENTS: Children (age 0–18 y) with community-acquired sepsis meeting Phoenix sepsis criteria admitted to a PICU directly or via an emergency department, who survived to 24 hours and had greater than or equal to 4 temperature measurements in the first 24 hours of admission were included. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 11,566 patients met all criteria for study inclusion. A total of 2327 patients (20%) developed the primary outcome of persistent multiple organ dysfunction syndrome (MODS) assessed at day 7 of admission. We used group-based trajectory modeling to identify temperature trajectory-based phenotypes. Three groups were identified: “hyperthermic” (35%), “normothermic” (59%), and “hypothermic” (6%), which were reproducible and had similar outcomes on a validation set. The “hypothermic” trajectory-based phenotype group had the highest odds of persistent MODS odds ratio (OR), 5 (95% CI, 4–6), and ICU mortality OR, 11 (95% CI, 9–15). In an exploratory analysis, hypothermia (< 35°C) at the time of PICU admission was also associated with persistent MODS and ICU mortality. The association between “hypothermic” trajectory-based phenotype and poor outcome remained after adjusting for hypothermia at admission, severity of illness, age, and technology dependence. CONCLUSIONS: We developed and validated temperature trajectory-based phenotypes of pediatric sepsis in a large multicenter cohort. The “hypothermic” trajectory-based phenotype was independently associated with worse clinical outcomes.


  • Open Access

    PPARγ Variant rs10865710 and Mortality in Pediatric Septic Shock Stratified by Corticosteroid Exposure

    by Valentina Bonnefil, Stephen Standage, Andrew J. Lautz, Natalja L. Stanski, Kelli Harmon, Patrick Lahni, Julie C. Fitzgerald, Adam J. Schwarz, Neal J. Thomas, Bereketeab Haileselassie, et al.

    OBJECTIVES: To determine whether genetic variation in peroxisome proliferator-activated receptor gamma (PPARγ) is associated with mortality across corticosteroid exposure strata in pediatric septic shock. DESIGN: Multicenter prospective observational study. SETTING: PICUs at multiple U.S. hospitals. PATIENTS: Children 1 week to 10 years old meeting consensus criteria for septic shock. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Genomic DNA was genotyped for two PPARγ single nucleotide variants (SNVs; rs10865710 and rs1801282) using TaqMan assays. Associations with 28-day mortality were evaluated using multivariable logistic regression and Cox proportional hazards models, with analyses stratified by systemic corticosteroid exposure within 72 hours. In a subset with whole-blood RNA sequencing, expression quantitative trait locus (eQTL) analyses assessed genotype effects on candidate transcripts. Among 381 patients, both SNVs were in Hardy-Weinberg equilibrium. Carriage of the rs10865710 mutant allele was associated with higher 28-day mortality (10.2% vs. 3.5%; p = 0.009), whereas rs1801282 showed no association. In stratified analyses, rs10865710 carriage was associated with increased mortality among corticosteroid-treated patients (adjusted odds ratio, 5.85; 95% CI, 1.62–30.44; p = 0.015) but not corticosteroid-naive patients. Similarly, in stratified Cox models, rs10865710 carriage was associated with increased hazard of death among corticosteroid-treated patients (hazard ratio, 5.33; 95% CI, 1.43–19.83; p = 0.013). Genotype was not associated with established mortality risk strata or transcriptomic endotype. In eQTL analyses ( n = 81), rs10865710 carriage was not associated with PPARγ expression; however, a trend toward lower glucocorticoid receptor ( NR3C1 ) expression was noted ( p = 0.07). CONCLUSIONS: The intronic PPARγ variant rs10865710 is associated with increased mortality in pediatric septic shock, with the association most apparent among corticosteroid-treated patients. Although no cis-eQTL effect on PPARγ expression was detected, exploratory data suggest potential differences in glucocorticoid receptor signaling. Prospective validation and mechanistic studies are warranted.

  • Rethinking triage for febrile children in low-resource settings

    by Mihir R. Atreya, Luregn J. Schlapbach

  • Open Access

    Deriving consensus sepsis clusters via goal-directed subgroup identification in multi-omics study

    by Zhongheng Zhang, Lin Chen, Hongjie Shen, Jing Wang, Jie Yang, Suibi Yang, Weimin Zhang, Xuandong Jiang, Xiaojun Wu, Xianglin Meng, et al.

    Sepsis, a syndrome of life-threatening organ dysfunction caused by dysregulated host responses to infection, exhibits profound pathobiological heterogeneity, hindering the development of effective therapies. Current subtyping approaches, often reliant on single-omics data or unsupervised clustering, yield poorly reproducible and therapeutically misaligned classifications. Here, we introduce a goal-directed subgroup identification (GD-SI) framework that optimizes patient stratification for differential treatment responses, integrating longitudinal multi-omics data (transcriptomic, proteomic, metabolomic, phenomic) from 1327 subjects across 43 hospitals. While supervised multi-omics integration frameworks (e.g., DIABLO) effectively capture shared biological signals, our approach anchors subgroup discovery directly to treatment-effect optimization. This strategy achieves substantial cross-omic concordance and, crucially, generalizes to predict differential treatment response across international critical care databases. Patients stratified by GD-SI-derived benefit scores for restrictive versus liberal fluid resuscitation exhibited marked survival differences, with similar advantages observed for ulinastatin immunomodulation. External validations in MIMIC-IV and ZiGongDB confirm prognostic generalizability. This framework reconciles biological heterogeneity with clinical actionability, offering a scalable infrastructure for precision trial design and personalized sepsis management. Our findings underscore the translational potential of omics-driven, goal-directed stratification to overcome decades of therapeutic stagnation in critical care.


  • Open Access

    Author Correction: A consensus immune dysregulation framework for sepsis and critical illnesses

    by Andrew R. Moore, Hong Zheng, Ananthakrishnan Ganesan, Yehudit Hasin-Brumshtein, Manoj V. Maddali, Joseph E. Levitt, Tom van der Poll, Jingyi Lu, Hjalmar R. Bouma, Brendon P. Scicluna, et al.


  • Top Cited Papers
    Open Access

    A consensus immune dysregulation framework for sepsis and critical illnesses

    by Andrew R. Moore, Hong Zheng, Ananthakrishnan Ganesan, Yehudit Hasin-Brumshtein, Manoj V. Maddali, Joseph E. Levitt, Tom van der Poll, Jingyi Lu, Hjalmar R. Bouma, Brendon P. Scicluna, et al.

    Critical care syndromes such as sepsis, acute respiratory distress syndrome (ARDS) and trauma continue to have unacceptably high morbidity and mortality, with progress limited by the inherent heterogeneity within syndromic illnesses. Although numerous immune endotypes have been proposed for sepsis and critical care, the similarities and differences between these endotypes remain unclear, hindering clinical translation. The SUBSPACE consortium is an international consortium that aims to advance precision medicine in critical care through the sharing of transcriptomic data. Here, evaluating the overlap of existing immune endotypes in sepsis across >7,074 samples from 37 independent cohorts, we developed cell-type-specific gene expression signatures to quantify dysregulation within immune compartments. Myeloid and lymphoid dysregulation were associated with disease severity and mortality across all cohorts. Importantly, this dysregulation was also observed in patients with ARDS, trauma and burns, suggesting a conserved mechanism across various critical illness syndromes. Moreover, analysis of randomized controlled trial data revealed that myeloid and lymphoid dysregulation are associated with differential mortality in patients treated with anakinra in the SAVE-MORE trial (n = 452) and corticosteroids in the VICTAS (n = 89) and VANISH (n = 117) trials, underscoring their prognostic and therapeutic implications. In conclusion, our proposed immunology-based framework for quantifying cellular compartment dysregulation offers a potentially valuable tool for understanding immune dysregulation in critical illness with prognostic and therapeutic significance.


  • Top Cited Papers
    Open Access

    Phoenix Sepsis Criteria in Critically Ill Children: Retrospective Validation Using a United States Nine-Center Dataset, 2012–2018

    by L. Nelson Md Sanchez-Pinto, Latasha A. Ma Daniels, Mihir Atreya, E. Vincent S. Md Faustino, Reid W. D. Farris, Alon Geva, Robinder G. Md Khemani, Colin Rogerson, Sareen S. Shah, Scott L. Md Weiss, et al.

    Objectives: To perform: 1) external validation of the Phoenix Sepsis Score and Phoenix sepsis criteria in a multicenter cohort of critically ill children with infection and a comparison with the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria; 2) a study of Phoenix sepsis criteria performance in patient subgroups based on age and comorbidities; 3) an assessment of microbiological profile of children with Phoenix sepsis; and 4) a study of the performance of the Phoenix-8 score. Design: Secondary, retrospective analysis of a multicenter cohort study from 2012 to 2018. Setting: Nine PICUs in the United States. Patients: PICU admissions with suspected infection. Interventions: None. Measurements and Main Results: Among 25,680 encounters of children with suspected or confirmed infection on PICU admission (4.6% in-hospital mortality), 11,168 (43%) met Phoenix criteria for sepsis or septic shock (9% in-hospital mortality). The Phoenix criteria generally outperformed the IPSCC criteria at discriminating mortality in all critically ill children with infections and across all subgroup analyses, including age group, malignancy, or technology dependence. Of 11,168 patients who met Phoenix criteria, 28% were negative for IPSCC criteria for sepsis and these had higher in-hospital mortality than those who met IPSCC sepsis criteria but not Phoenix criteria (4.7% vs.1.7%; p < 0.001), which was similar to the mortality of patients without sepsis (1.3%). Sepsis was associated with respiratory or bloodstream infection, most commonly Pseudomonas aeruginosa or Staphylococcus aureus. The Phoenix-8 score had good discrimination of mortality in children with infections, comparable to or better than validated and widely used severity of illness and organ dysfunction scores. Conclusions: In 2012–2018, among U.S. patients with suspected or confirmed infection admitted to nine PICUs, those with the highest risk of mortality can be identified using the Phoenix sepsis criteria, including in children of different age groups and those with major comorbidities.


  • Open Access

    Derivation and Validation of a Clinical and Endothelial Biomarker Risk Model to Predict Persistent Pediatric Sepsis-Associated Acute Respiratory Dysfunction

    by James G. Williams, Jane E. Whitney, Scott L. Weiss, Brian M. Varisco, Nadir Yehya, Mihir R. Atreya